AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
Chronic Kidney Disease Resources
Chronic Kidney Disease Resources
Chronic Kidney Disease is when the kidneys gradually get damaged over time and the kidneys are unable to complete functions such as removing wastes from your body, maintain blood pressure, and keeping your bones healthy.
Signs of chronic kidney disease include:
- Itchy or dry skin
- Nausea
- Weight loss
- Loss of appetite
- Fatigue
- Irregular urinating patterns
- Concentration issues
- Muscle cramps
- High blood pressure
Diseases and conditions that can cause chronic kidney disease include:
- Type 1 or 2 diabetes
- High blood pressure
- Obesity
- Heart disease
- Family history
- Glomerular diseases
- Inherited conditions
- Autoimmune conditions
- Severe infections
Treatment of chronic kidney disease:
- Following instructions when using medication
- Maintain healthy weight
- Avoid smoking
Journal of Managed Care + Specialty Pharmacy Publications
- Descriptive Study of the Economic Burden Among Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Chronic Kidney Disease and Type 2 Diabetes Mellitus in a Large US Commercially Insured Population. Journal of Managed Care + Specialty, 2022, Dec;29(1):80-89.
- Costs Associated With the Administration of Erythropoiesis-Stimulating Agents for the Treatment of Anemia in Patients With Non-Dialysis-Dependent Chronic Kidney Disease: A US Societal Perspective. Journal of Managed Care + Specialty, 2021 Nov;27(11):1703-1713.
- Association of Dyskalemias With Short-Term Health Care Utilization in Patients With Advanced CKD. Journal of Managed Care + Specialty, 2021 Oct;27(10):1403-1415.
Additional Publications
- C3 Glomerulopathy: Understanding an Ultra-Rare Complement-Mediated Renal Disease. Heiderscheit A K, Hauer J J, Smith R J H. American Journal of Medical Genetics, 2022, Sep. doi: 10.1002/ajmg.c.31986.
- Clinico-Pathogenic Similarities and Differences Between Infection-Related Glomerulonephritis and C3 Glomerulopathy. Wada Y, Kamata M, Miyasaka, et al. Int J Mol Sci, 2023, May. doi: 10.3390/ijms24098432.
- Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein. Urban A, Kowalska D, Stasilojc G, et al. Frontiers In Immunology, 2021, Nov. doi: 10.3389/fimmu.2021.724361.
Sponsored by Apellis
©2025 Apellis Pharmaceuticals, Inc. All rights reserved. 1/25 US-C3G-2500007 v1.0
Related
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
View our webinar on Managed Care Approaches to Address Unmet Patient Needs in Multiple Sclerosis (MS), a disease affecting nearly 1 million people in the U.S. Despite advancements in treatment, significant gaps remain in access, affordability, and comprehensive care.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
